The US startup Neuralink, which recently implanted one of its chips into the brain of a young quadriplegic man for the first time, has been forced to halt the trial. The company, co-founded by Elon Musk, encountered issues just a few weeks after the operation but has already received FDA approval to find a second test subject. FRANCE 24’s Julia Sieger tells us more.
Source link
Trending
- Don Cheadle, Ayo Edibiri Talk Making Broadway Debuts in ‘Proof’
- U.S. equity fund inflows rise on earnings optimism, AI boost
- Mines in the Strait of Hormuz: How dangerous are they?
- Meta to cut one in 10 jobs after spending billions on AI
- Disney+ slashes prices in surprise deal as rivalry with HBO Max heats up – but you’ll have to act fast for discount
- Waarom kinderen zich vaker moeten vervelen: ‘Goed voor de veerkracht’
- What NHS challenges does the election winner face?
- Meta lines up layoffs while Microsoft offers buyouts | Business and Economy News
